RT Journal Article
SR Electronic
T1 Mental health, substance use and viral load suppression in adolescents receiving ART at a large paediatric HIV clinic in South Africa
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2020.07.06.20147298
DO 10.1101/2020.07.06.20147298
A1 Haas, Andreas D.
A1 Technau, Karl-Günter
A1 Pahad, Shenaaz
A1 Braithwaite, Kate
A1 Madzivhandila, Mampho
A1 Sorour, Gillian
A1 Sawry, Shobna
A1 Maxwell, Nicola
A1 Groote, Per von
A1 Tlali, Mpho
A1 Davies, Mary-Ann
A1 Egger, Matthias
A1 for the IeDEA Southern Africa Collaboration
YR 2020
UL http://medrxiv.org/content/early/2020/07/07/2020.07.06.20147298.abstract
AB Introduction There are few data on the prevalence of mental health problems among adolescents living with HIV in low- and middle-income countries and the evidence on associations between mental health problems and viral load suppression is inconsistent. We assessed the prevalence of mental health problems among adolescents receiving antiretroviral therapy (ART) at a large paediatric HIV clinic in South Africa and examined associations between mental health problems and viral load suppression.Methods We implemented routine mental health screening at Rahima Moosa Mother and Child Hospital in Johannesburg. Adolescents aged 10-19 years were offered screening for depression (Patient Health Questionnaire-9 [PHQ-9]), suicide (Adolescent Innovations Project [AIP]-handbook), anxiety (General Anxiety Disorder-7 [GAD-7]), trauma (Primary Care PTSD Screen for DSM-5 [PC-PTSD-5]), and substance use (CAGE Adapted to Include Drugs [CAGE-AID]) at each routine HIV care visits. We assessed screening outcomes between February 1, 2018, and January 1, 2020 and calculated odds ratios for associations between positive screening outcomes and unsuppressed viral load (>400 HIV-RNA copies/ml).Results Out of 1,203 adolescents who attended the clinic, 1,088 (90.4%) were screened at a median age of 13 years (IQR 10-15). In total, 97 (8.9%) screened positive: 48 (4.4%) for depression (PHQ-9 ≥ 10), 29 (2.8%) for suicidal concern, 24 (2.2%) for anxiety (GAD-7 ≥ 10), 38 (3.2%) for trauma (PC-PTSD-5 ≥ 3), and 18 (1.7%) for substance use (CAGE-AID ≥ 2). Positive screening for depression (aOR 2.39, 95% CI 1.02-5.62), trauma (aOR 3.18, 95% CI 1.11-9.07), substance use (aOR 7.13, 95% CI 1.60-31.86), or any mental health condition (aOR 2.17, 95% CI 1.17-4.02) were strongly associated with unsuppressed viral load.Conclusions HIV-positive adolescents who are affected by mental health or substance use problems are a highly vulnerable population, who merit specific clinical attention. Strategies for screening and management of mental health and substance use problems in adolescents on ART in low- and middle-income countries need to be developed and evaluated.Competing Interest StatementThe authors have declared no competing interest.Clinical TrialRoutinely collected program data were usedFunding StatementResearch reported in this publication was supported by the U.S. National Institutes of Health National Institute of Allergy and Infectious Diseases, the Eunice Kennedy Shriver National Institute of Child Health and Human Development, the National Cancer Institute, the National Institute of Mental Health, the National Institute on Drug Abuse, the National Heart, Lung, and Blood Institute, the National Institute on Alcohol Abuse and Alcoholism, the National Institute of Diabetes and Digestive and Kidney Diseases and the Fogarty International Center under Award Number U01AI069924. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:The clinic has institutional ethical approval for the contribution of data to IeDEA. The Human Research Ethics Committee of the University of Cape Town, SA and the Cantonal Ethics Committee, Bern, Switzerland granted permission for analysis of this database. Institutional review boards have granted waivers of informed consent as the analyses use only de-identified data that are collected as part of routine patient care.All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesAll data were obtained from the International epidemiology Database to Evaluate AIDS Southern Africa collaboration (IeDEA-SA, https://www.iedea-sa.org/). Data cannot be made available online because of legal and ethical restrictions. To request data, readers may contact IeDEA for consideration by filling out the online form available at https://www.iedea-sa.org/contact-us/.